Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $729 | $670 | $814 | $1,186 |
| - Cash | $43 | $36 | $33 | $125 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $688 | $637 | $784 | $1,064 |
| Revenue | $40 | $34 | $31 | $29 |
| % Growth | 17.4% | 10.2% | 5.3% | – |
| Gross Profit | $35 | $30 | $28 | $26 |
| % Margin | 88.7% | 88.9% | 90.6% | 89.8% |
| EBITDA | -$19 | -$29 | -$35 | -$58 |
| % Margin | -47.2% | -86.6% | -114.1% | -200.2% |
| Net Income | -$20 | -$30 | -$36 | -$66 |
| % Margin | -49.6% | -89.4% | -117% | -225% |
| EPS Diluted | -0.19 | -0.29 | -0.35 | -0.7 |
| % Growth | 34.5% | 17.1% | 50% | – |
| Operating Cash Flow | -$6 | -$25 | -$59 | -$30 |
| Capital Expenditures | $0 | $3 | -$4 | -$1 |
| Free Cash Flow | -$6 | -$21 | -$63 | -$31 |